Intraepithelial neoplasia is a medical term pathologists use to describe abnormal cells or growths that are found only within the epithelium, the thin layer of tissue that lines and protects body surfaces and internal organs. The word “neoplasia” means new growth, which can be precancerous or early-stage cancer, and “intraepithelial” means it hasn’t spread beyond the surface lining into deeper tissues.
When your pathology report mentions intraepithelial neoplasia, it indicates an early-stage precancerous growth confined to the lining of a tissue or organ. Because these cells have not yet spread deeper, it’s generally easier to treat and manage effectively. Detecting and treating intraepithelial neoplasia early helps prevent the development of invasive cancer.
Intraepithelial neoplasia can occur in various parts of the body. Some common examples include:
Cervical intraepithelial neoplasia (CIN): Abnormal cells on the cervix, often caused by human papillomavirus (HPV), which can progress to cervical cancer if untreated.
Prostatic intraepithelial neoplasia (PIN): Changes in prostate gland cells that may precede prostate cancer.
Anal intraepithelial neoplasia (AIN): Precancerous cells in the anus, frequently linked to HPV infection.
Vulvar or vaginal intraepithelial neoplasia (VIN and VaIN): Precancerous changes affecting the vulva or vagina, often associated with HPV.
Squamous intraepithelial neoplasia: Precancerous squamous cells that can occur in areas such as the skin or oral cavity.
No, intraepithelial neoplasia is not cancer. Instead, it is considered a precancerous growth, meaning that the abnormal cells have not yet developed into cancer. However, if left untreated, these precancerous cells may eventually turn into invasive cancer over time. Early detection and treatment help prevent this progression and lower the risk of developing cancer.
If your pathology report mentions intraepithelial neoplasia, your doctor will typically recommend additional testing, closer monitoring, or treatment to remove or manage these abnormal cells. Regular follow-up care is important to ensure these changes are effectively treated and to prevent progression to invasive cancer.